Funding News

The LEX VELO PCR platform is at the center of an estimated £28m funding round for Lex Diagnostics Limited. Based in Pencoed, the company develops and manufactures point-of-care molecular diagnostics s...

A post-money valuation of £3.7m has been reached by Watercress Research Ltd following its latest £50k funding round. Based in Exeter, the company was incorporated in 2019 to develop urease inhibitory ...

Pencil Biosciences Limited is a Macclesfield-based biotechnology firm founded in 2018. The company develops a proprietary, synthetic, modular, non-CRISPR gene-editing and modulation platform for treat...

Okulo Ltd, a Bristol-based company founded in 2018, develops training technology using light science to enhance visual processing for athletes. Trading as OKKO Health and OKKULO, the firm focuses on i...

MFM Synbio Ventures UG has joined the cap table of Bactobio Ltd, according to the company latest confirmation statement (filed 2 June 2026). The new investor acquired 19 Ordinary shares in the London-...

Small molecule somatic expansion inhibitors developer Loqus23 Therapeutics has secured an estimated £15m in capital. Based in Great Abington, the biotechnology firm targets DNA instability to slow neu...

Zoevis Inc has joined the cap table of Firglas Ltd as a new shareholder, holding 74,215 Ordinary shares. This entry makes Zoevis Inc the largest shareholder listed in the latest confirmation statement...

Flight Lease Capital Partners LLC and Spouting Whale II LLC have joined the cap table of Firglas Ltd, each acquiring a holding of 636 ordinary shares. The London based company, which was incorporated ...

Cardiff-based Antiverse has secured an estimated £3m Series A round to advance its machine learning platform for antibody discovery. The techbio company specializes in designing de novo antibody thera...

Developing an oral small molecule therapy for thyroid eye disease is the primary focus of Altrincham-based Sling Therapeutics UK Limited. The biopharmaceutical company is currently engaged in the late...

Developing drug treatments for patients with underserved genetic conditions is the core focus of Cycle Group Holdings Limited, which has just raised an estimated £1.7m. The Cambridge-based pharmaceuti...

An estimated £200k has been raised by Optigenomics Limited in its latest funding round. This capital injection follows a period of frequent fundraising for the London-based business, which previously ...

Stokenchurch-based Antigenika Ltd has secured an estimated £589.9k in a new funding round to support the development of oral combination therapies for snakebite envenoming. The company, which was inco...

An estimated £1.6m has been raised by Osler Diagnostics to support the development of its portable diagnostic technology. The Oxford-based company focuses on the Osler Origin, a high-performance instr...

Bristol-based Mykor Ltd has secured an estimated £2.7m in a seed funding round to scale its bio-based insulation and building systems. The company develops products such as MykoSIP and MykoSlab using ...

Developing cancer immunotherapies from genomic dark matter, Enara Bio Limited has raised an estimated £67.7k in its latest funding round. Based in Oxford, the biopharmaceutical company discovers Dark ...

Oxford-based Refeyn Ltd has raised £56k in a new funding round, resulting in an estimated post-money valuation of £5.3m. The company specializes in mass photometry, a bioanalytical technology used to ...

Targeting DNA Damage Repair deficiencies in cancer is the primary objective of Duke Street Bio, which has recently secured an estimated £10.8m in fresh capital. The London-based biotechnology company ...

Modular synthetic fuel plants are the focus of a new £17.6m Series A funding round for London-based Rivan Industries Ltd. The company designs and constructs vertically integrated facilities that produ...

Regenerating nerve cells to restore natural hearing is the primary focus of Camgene Therapeutics Limited, which has just secured £260k in Series A funding. Based in Cambridge, the biotechnology compan...

Spirea Limited is advancing its proprietary ELIVATE linker technology following a new funding round of £195.4k. Based in Harrogate, the biotech company focuses on the development of next-generation An...

Altrincham-based Cytospire Therapeutics has secured £3.4m in Series A funding to advance its development of next-generation multispecific antibodies. The company focuses on pan-gamma delta T cell enga...

Providing lab-quality diagnostic information at the point-of-need is the primary objective of Fuse Diagnostics Limited, which has secured £99.9k in its latest funding round. Based in Saint Ives, the b...

An estimated £350k has been raised by Better Origin Holdings Limited to support its biotechnology research and animal production activities. This latest investment places the London-based company at a...

Providing a patented human cell-based platform for gene therapy safety testing, Testavec Limited has secured £73k in its latest funding round. The Maidenhead-based company operates a human induced plu...

Advanced biomaterials developer Kalvotech Limited has secured an estimated £70k in its latest funding round. Based in Southsea, the company focuses on biotech innovation through the production of nove...

Developing blood-based tests for early liver cancer detection, Cambridge-based Mursla Bio has secured an estimated £150k in its latest funding round. Founded in 2017 as a spin-out from the University ...

Developing high-performance biopolymers from renewable sources is the core focus of Demeter Bio, a London-based biotechnology firm. The company aims to provide bio-based alternatives for the materials...

Developing antibody therapies to reverse amyloidosis is the core mission of Cambridge-based Immutrin, which has just closed a significant funding round. The biotechnology firm secured an estimated £19...

Research and manufacturing of cannabinoid-based pharmaceutical medicines (CBPMs) is the core focus of 113 Botanicals Limited, which has recently secured an estimated £220k in new funding. Based in Sou...